Home Page About Us Services Question-ERR Contact Us News and Info Links

Question-ERR® - April 2004
Results

<< Back to list   |   Print

Issues Related to the Impact of Risk Management Programs that Utilize Stickers

Country of Practice
USA 81%
International 1%

1. Are you aware of the risk management programs that require physicians to use stickers before a pharmacist can dispense a medication?

No 18%
Yes 63%

2. Have you received a prescription, as a written document, a verbal order or as a FAX, for a medication that required a special sticker on the prescription in order for you to dispense the medication?

No 43%
Yes 38%


3. About how often have you received a prescription for a medication that required a special sticker but the sticker was missing?

Almost always 5%
Frequently 5%
Never 46%
Sometimes 19%

5. What procedure did you follow when the sticker was missing?

did not dispense the drug 14%
dispensed the drug after calling the drug company for further program information 1%
dispensed the drug after calling the prescriber 7%
dispensed the drug after verifying with the patient that the appropriate criteria have been met 3%
dispensed the drug with no further inquiry 1%
other 14%

Please indicate if you have received educational materials about the Risk Management Program for any of the following medications

ACCUTANE 100%
ACTIQ 18%
CLOZARIL 68%
LOTRONEX 24%
MIFEPREX 4%
THALOMID 54%
TIKOSYN 38%
TRACLEER 9%
TROVAN 10%
XYREM 4%
Others 1%

For the previous list of medications, how were you notified of the prescribing restrictions?

Letters from the product manufacturer 93%
Manufacturer sponsored training programs 19%
Continuing education 29%
Public notices 23%
Patient package inserts other product specific materials 54%
Colleagues at work 41%
I received no formal notification of the prescribing restrictions 8%
other 7%